20 results
8-K
EX-99.1
MAIA
MAIA Biotechnology Inc
4 Jun 24
Regulation FD Disclosure
4:06pm
is designed to incentivize the development of therapies that demonstrate promise for the 3x treatment of rare (orphan) diseases or conditions Rare disease
8-K
EX-99.1
MAIA
MAIA Biotechnology Inc
13 Nov 23
Other Events
6:07am
Designation
The FDA’s Orphan Drug Act of 1983 was designed to incentivize the development of therapies that demonstrate promise for the treatment
DRS
MAIA
MAIA Biotechnology Inc
1 Jun 23
Draft registration statement
12:00am
and appropriately incentivize qualified individuals, generate sufficient sales leads, provide adequate training to sales and marketing personnel, oversee
424B4
qfbzjodjx99atk9t
25 Apr 23
Prospectus supplement with pricing info
7:45pm
DRS
hsr43 qyuyvpx4
23 Dec 22
Draft registration statement
12:00am
424B4
ixo3e1dvx pmmi
29 Jul 22
Prospectus supplement with pricing info
8:31am
S-1
m7928qqhhaitqmv7nq
8 Apr 22
IPO registration
8:21pm
DRS/A
36qwa0 g4i
22 Dec 21
Draft registration statement (amended)
12:00am
DRS
eeb1e
15 Oct 21
Draft registration statement
12:00am
- Prev
- 1
- Next